It has become a minimally invasive treatment for glaucoma.[12] Potential complications of anti-VEGF therapy include vision loss, uveitis, hypotony, and rarely atrophy of eyeball.[13–15] To avoid the complications, we photocoagulated at 4- and 6-o’clock regions and only 15 points. This evidence concerns the gene VEGFA and uveitis.